DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma

Carcinogenesis

Volumn 28, Issue 2, 2007, Pages 246-258

  Boireau, Stéphanie ^a   Samuel, Michael S ^a   Pannequin, Julie ^b   Ryan, Joanne L ^a,g   Choquet, Armelle ^a   Chapuis, Heliette ^c   Rebillard, Xavier ^d   Avancès, Christophe ^c,e   Ernst, Matthias ^b   Joubert, Dominique ^a   Mottet, Nicolas ^c,f   Hollande, Frédéric ^a,h  

^a UNIV MONTPELLIER   (France)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c NÎMES UNIVERSITY HOSPITAL   (France)

^d Clinique Beausoleil   (France)

^e Polyclinique Kennedy   (France)

^f Clinique Mutualiste   (France)

^g CNRS   (France)

^h INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 1; CLAUDIN 4; CLAUDIN 7; DNA; DNA METHYLTRANSFERASE 3A; METHYLTRANSFERASE INHIBITOR; SMALL INTERFERING RNA;

ANIMAL TISSUE; ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CANCER GRADING; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; GENE OVEREXPRESSION; GENE SEQUENCE; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UROTHELIUM;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOWN-REGULATION; HUMANS; MEMBRANE PROTEINS; MICE; RNA, SMALL INTERFERING; URINARY BLADDER NEOPLASMS;

EID: 33847279453     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl120     Document Type: Article

References (54)

1. Matter,K. and Balda,M.S. (2003) Signalling to and from tight junctions. Nat. Rev. Mol. Cell Biol., 4, 225-236.
2. Schneeberger,E.E. and Lynch,R.D. (2004) The tight junction: A multi-functional complex. Am. J. Physiol. Cell Physiol., 286, C1213-C1228.
3. Kohler,K. and Zahraoui,A. (2005) Tight junction: A co-ordinator of cell signalling and membrane trafficking. Biol. Cell, 97, 659-665.
4. Cereijido,M., Shoshani,L. and Contreras,R.G. (2000) Molecular physiology and pathophysiology of tight junctions. I. Biogenesis of tight junctions and epithelial polarity. Am. J. Physiol. Gastrointest. Liver Physiol., 279, G477-G482.
5. Tsukita,S. and Furuse,M. (2000) Pores in the wall: Claudins constitute tight junction strands containing aqueous pores. J. Cell. Biol., 149, 13-16.
6. Blanco,D., Vicent,S., Elizegi,E., Pino,I., Fraga,M.F., Esteller,M., Saffiotti,U., Lecanda,F. and Montuenga,L.M. (2004) Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis. Lab. Invest., 84, 999-1012.
7. Haynes,M.D., Martin,T.A., Jenkins,S.A., Kynaston,H.G., Matthews,P.N. and Jiang,W.G. (2005) Tight junctions and bladder cancer (review). Int. J. Mol. Med., 16, 3-9.
8. Acharya,P., Beckel,J., Ruiz,W.G., Wang,E., Rojas,R., Birder,L. and Apodaca,G. (2004) Distribution of the tight junction proteins ZO-1, occludin, and claudin-4, -8, and -12 in bladder epithelium. Am. J. Physiol. Renal. Physiol., 287, F305-F318.
9. Langbein,L., Grund,C., Kuhn,C., Praetzel,S., Kartenbeck,J., Brandner,J.M., Moll,I. and Franke,W.W. (2002) Tight junctions and compositionally related junctional structures in mammalian stratified epithelia and cell cultures derived therefrom. Eur. J. Cell Biol., 81, 419-435.
10. Mysorekar,I.U., Mulvey,M.A., Hultgren,S.J. and Gordon,J.I. (2002) Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli. J. Biol. Chem., 277, 7412-7419.
11. Ladwein,M., Pape,U.F., Schmidt,D.S., Schnolzer,M., Fiedler,S., Langbein,L., Franke,W.W., Moldenhauer,G. and Zoller,M. (2005) The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7. Exp. Cell. Res., 309, 345-357.
12. Hough,C.D., Sherman-Baust,C.A., Pizer,E.S., Montz,F.J., Im,D.D., Rosenshein,N.B., Cho,K.R., Riggins,G.J. and Morin,P.J. (2000) Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer. Res., 60, 6281-6287.
13. Johnson,A.H., Frierson,H.F., Zaika,A., Powell,S.M., Roche,J., Crowe,S., Moskaluk,C.A. and El-Rifai,W. (2005) Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis. Am. J. Pathol., 167, 577-584.
14. Nichols,L.S., Ashfaq,R. and Iacobuzio-Donahue,C.A. (2004) Claudin 4 protein expression in primary and metastatic pancreatic cancer: Support for use as a therapeutic target. Am. J. Clin. Pathol., 121, 226-230.
15. Hibbs,K., Skubitz,K.M., Pambuccian,S.E., Casey,R.C., Burleson,K.M., Oegema,T.R.,Jr, Thiele,J.J., Grindle,S.M., Bliss,R.L. and Skubitz,A.P. (2004) Differential gene expression in ovarian carcinoma: Identification of potential biomarkers. Am. J. Pathol., 165, 397-414.
16. Kominsky,S.L., Vali,M., Korz,D., Gabig,T.G., Weitzman,S.A., Argani,P. and Sukumar,S. (2004) Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am. J. Pathol., 164, 1627-1633.
17. Michl,P., Buchholz,M., Rolke,M., Kunsch,S., Lohr,M., McClane,B., Tsukita,S., Leder,G., Adler,G. and Gress,T.M. (2001) Claudin-4: A new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology, 121, 678-684.
18. Santin,A.D., Cane,S., Bellone,S., Palmieri,M., Siegel,E.R., Thomas,M., Roman,J.J., Burnett,A., Cannon,M.J. and Pecorelli,S. (2005) Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin. Cancer. Res., 65, 4334-4342.
19. Dhawan,P., Singh,A.B., Deane,N.G., No,Y., Shiou,S.R., Schmidt,C., Neff,J., Washington,M.K. and Beauchamp,R.D. (2005) Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J. Clim Invest., 115, 1765-1776.
20. Resnick,M.B., Konkin,T., Routhier,J., Sabo,E. and Pricolo,V.E. (2005) Claudin-1 is a strong prognostic indicator in stage II colonic cancer: A tissue microarray study. Mod. Pathol., 18, 511-518.
21. Borlak,J., Meier,T., Halter,R., Spanel,R. and Spanel-Borowski,K. (2005) Epidermal growth factor-induced hepatocellular carcinoma: Gene expression profiles in precursor lesions, early stage and solitary tumours. Oncogene., 24, 1809-1819.
22. Kominsky,S.L., Argani,P., Korz,D., Evron,E., Raman,V., Garrett,E., Rein,A., Sauter,G., Kallioniemi,O.P. and Sukumar,S. (2003) Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene, 22, 2021-2033.
23. Saito,T. (1984) Ultrastructural changes on the junctional complexes in the human urinary bladder carcinoma by thin sectioning and freeze fracture. J. Clin. Electron Micros., 17, 201-209.
24. Hollande,F., Lee,D.J., Choquet,A., Roche,S. and Baldwin,G.S. (2003) Adherens junctions and tight junctions are regulated via different pathways by progastrin in epithelial cells. J. Cell. Sci., 116, 1187-1197.
25. Sobin,L.H. and Wittekind,C. (eds) TNM Classification of Malignant Tumours. (2002). John Wiley & Sons, New York.
26. EpsteinJ.I., Amin,M.B., Reuter,V.R. and Mostofi,F.K. (1998) The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am. J. Surg. Pathol., 22, 1435-1448.
27. Takai,D. and Jones,P.A. (2003) The CpG island searcher: A new WWW resource. In. Silico. Biol., 3, 235-240.
28. Li,L.C. and Dahiya,R. (2002) MethPrimer: Designing primers for methylation PCRs. Bioinformatics, 18, 1427-1431.
29. Johnstone,C.N., Tebbutt,N.C., Abud,H.E. et al. (2000) Characterization of mouse A33 antigen, a definitive marker for basolateral surfaces of intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol., 279, G500-G510.
30. Johnstone,C.N., White,S.J., Tebbutt,N.C., Clay,F.J., Ernst,M., Biggs,W.H., Viars,C.S., Czekay,S., Arden,K.C. and Heath,J.K. (2002) Analysis of the regulation of the A33 antigen gene reveals intestine-specific mechanisms of gene expression. J. Biol. Chem., 277, 34531-34539.
31. Tebbutt,N.C., Giraud,A.S., Inglese,M. et al. (2002) Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med., 8, 1089-1097.
32. Swisshelm,K., Macek,R. and Kubbies,M. (2005) Role of claudins in tumorigenesis. Adv. Drug. Deliv. Rev., 57, 919-928.
33. Mullin,J.M., Agostino,N., Rendon-Huerta,E. et al. (2005) Keynote review: epithelial and endothelial barriers in human disease. Drug. Discov. Today, 10, 395-408.
34. Takai,D. and Jones,P.A. (2002) Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl Acad. Sci. USA, 99, 3740-3745.
35. Robertson,K.D., Uzvolgyi,E., Liang,G., Talmadge,C., Sumegi,J., Gonzales,F.A. and Jones,P.A. (1999) The human DNA methyltransferases (DNMTs) 1, 3a and 3b: Coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res., 27, 2291-2298.
36. Oka,M., Meacham,A.M., Hamazaki,T., Rodic,N., Chang,L.J. and Terada,N. (2005) De novo DNA methyltransferases Dnmt3a and Dmnt3b primarily mediate the cytotoxic effect of 5-aza-2′-deoxycytidine. Oncogene, 24, 3091-3099.
37. Ting,A.H., Jair,K.W., Schuebel,K.E. and Baylin,S.B. (2006) Differential requirement for DNA methyltransferase 1 in maintaining human cancer cell gene promoter hypermethylation. Cancer Res., 66, 729-735.
38. Ribeiro-Filho,L.A., Franks,J., Sasaki,M. et al. (2002) CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Mol. Carcinog., 34, 187-198.
39. Michl,P., Barth,C., Buchholz,M. et al. (2003) Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res., 63, 6265-6271.
40. Agarwal,R., D'Souza,T. and Morin,P.J. (2005) Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res., 65, 7378-7385.
41. Lu,K.H., Patterson,A.P., Wang,L. et al. (2004) Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin. Cancer Res., 10, 3291-3300.
42. Katoh,M. (2003) CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. Int. J. Mol. Med., 11, 683-689.
43. Kramer,F., White,K., Kubbies,M., Swisshelm, K. and Weber,B.H. (2000) Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum. Genet., 107, 249-256.
44. Herman,J.G. and Baylin,S.B. (2003) Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med., 349, 2042-2054.
45. Archey,W.B., McEachern,K.A., Robson,M., Offit,K., Vaziri,S.A., Casey,G., Borg,A. and Arrick,B.A. (2002) Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers. Oncogene., 21, 7034-7041.
46. Miwa,N., Furuse,M., Tsukita,S., Niikawa,N., Nakamura,Y. and Furukawa,Y. (2000) Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol. Res., 12, 469-476.
47. Rangel,L.B., Agarwal,R., D'Souza,T., Pizer,E.S., Alo,P.L., Lancaster,W.D., Gregoire,L., Schwartz,D.R., Cho,K.R. and Morin,P.J. (2003) Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin. Cancer Res., 9, 2567-2575.
48. Matsuda,M., Kubo,A., Furuse,M. and Tsukita,S. (2004) A peculiar internalization of claudins, tight junction-specific adhesion molecules, during the intercellular movement of epithelial cells. J. Cell Sci., 117, 1247-1257.
49. Muller,D., Kausalya,P.J., Claverie-Martin,F., Meij,I.C., Eggert,P., Garcia-Nieto, V. and Hunziker,W. (2003) A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting. Am. J. Hum. Genet., 73, 1293-1301.
50. Plachot,C. and Lelievre,S.A. (2004) DNA methylation control of tissue polarity and cellular differentiation in the mammary epithelium. Exp. Cell Res., 298, 122-132.
51. Heiskala,M., Peterson,P.A. and Yang,Y. (2001) The roles of claudin superfamily proteins in paracellular transport. Traffic, 2, 93-98.
52. Colegio,O.R., Van Itallie,C., Rahner,C. and Anderson,J.M. (2003) Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am. J. Physiol. Cell Physiol., 284, C1346-C1354.
53. Van Itallie,C., Rahner,C. and Anderson,J.M. (2001) Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J. Clin. Invest., 107, 1319-1327.
54. Mroczkowski,B. and Reich,M. (1993) Identification of biologically active epidermal growth factor precursor in human fluids and secretions. Endocrinology, 132, 417-425.